| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/16/2009 | WO2009046832A2 Short peptides used in medicine |
| 04/16/2009 | WO2009046831A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046830A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046829A2 Casoxin d as a therapeutic agent |
| 04/16/2009 | WO2009046827A2 Use of growth hormone-releasing factor and/or mage-3 antigen (271-279) as therapeutic agents |
| 04/16/2009 | WO2009046826A1 Use of a cyclic penta-peptide as a therapeutic agent |
| 04/16/2009 | WO2009046825A1 Use of a peptide acetyl-calpastatin as a therapeutic agent |
| 04/16/2009 | WO2009046824A2 Use of apelin-12 as a therapeutic agent, eg for treating excessive angiogenesis |
| 04/16/2009 | WO2009046823A1 Exendin-3 and apelin-12 for therapeutic applications |
| 04/16/2009 | WO2009046822A2 Use of the peptide ymdgtmsqv as a therapeutic agent |
| 04/16/2009 | WO2009046640A1 Myrothecium sp. mycelial extract for inhibiting tumor cells growth |
| 04/16/2009 | WO2009046606A1 Pyrimidinyl-propionic acid derivatives and their use as ppar agonists |
| 04/16/2009 | WO2009046530A1 Compositions affecting hyaluronic acid mediated activity |
| 04/16/2009 | WO2009027994A3 NOVEL STEROIDAL ESTERS OF 17-OXIMINO-5-ANDROSTEN-3β-OL |
| 04/16/2009 | WO2009021992A3 Fused bicyclic pyrimidines |
| 04/16/2009 | WO2009018667A8 Plant bioreactor for the production of interleukin-24 cytokine |
| 04/16/2009 | WO2009016516A8 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 04/16/2009 | WO2009014702A3 Cd74 for use in the treatment of cancer and liver toxicity |
| 04/16/2009 | WO2009006043A3 Potentiation of cancer chemotherapy by 7-(2,5-dihydro-4-imidazo [1,2-a]pyrine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyd-pyrrolo[3,2,1-jk][1,4]benzodiazepine |
| 04/16/2009 | WO2009002538A3 Amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib |
| 04/16/2009 | WO2009000832A3 Chemical compounds |
| 04/16/2009 | WO2008153947A3 Heterocyclic compounds as raf kinase modulators |
| 04/16/2009 | WO2008148849A3 Piperidine/piperazine derivatives |
| 04/16/2009 | WO2008136848A4 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease |
| 04/16/2009 | WO2008067027A3 Compositions of chkl inhibitors and cyclodextrin |
| 04/16/2009 | WO2008032072A8 2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 04/16/2009 | WO2008015340A3 Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapuetic application thereof |
| 04/16/2009 | WO2006012359A3 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/16/2009 | WO2005042727A3 Methods of organ regeneration |
| 04/16/2009 | US20090099341 Heparanase specific molecular probes and their use in research and medical applications |
| 04/16/2009 | US20090099252 Novel laulimalide analogues as therapeutic agents |
| 04/16/2009 | US20090099246 Veliparib crystal structure; an anticancer PARP inhibitor |
| 04/16/2009 | US20090099245 Title compound is Veliparib, a Poly(ADP-ribose) polymerase i.e. PARP inhibitor; anticancer agent |
| 04/16/2009 | US20090099230 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 04/16/2009 | US20090099224 C7- substituted camptothecin analogs |
| 04/16/2009 | US20090099223 Methods of treating hormone-related conditions using thio-oxindole derivatives |
| 04/16/2009 | US20090099221 Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors |
| 04/16/2009 | US20090099219 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 04/16/2009 | US20090099218 Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs |
| 04/16/2009 | US20090099213 Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases Inhibitors |
| 04/16/2009 | US20090099210 Enantiomers of selected fused heterocyclics and uses thereof |
| 04/16/2009 | US20090099208 Novel guanidine derivatives and their medical use |
| 04/16/2009 | US20090099203 Composition 064 |
| 04/16/2009 | US20090099197 Methods of Identifying and Treating Individuals Exhibiting MDR-1 Overexpression With Protein Tyrosine Kinase Inhibitors and Combinations Thereof |
| 04/16/2009 | US20090099196 Chemical Process |
| 04/16/2009 | US20090099194 CXCR4 Antagonists Including Diazine And Triazine Structures For The Treatment Of Medical Disorders |
| 04/16/2009 | US20090099191 Inhibition of nf-kb |
| 04/16/2009 | US20090099190 Kinase inhibitors useful for the treatment of proliferative diseases |
| 04/16/2009 | US20090099183 Pyrimidines and uses thereof |
| 04/16/2009 | US20090099181 Sulfoximines as kinase inhibitors |
| 04/16/2009 | US20090099178 Indazole compounds and methods of use thereof |
| 04/16/2009 | US20090099174 Combination 059 |
| 04/16/2009 | US20090099171 Diazaquinolones that inhibit prolyl hydroxylase activity |
| 04/16/2009 | US20090099167 Organic compounds |
| 04/16/2009 | US20090099166 C10-substituted camptothecin analogs |
| 04/16/2009 | US20090099161 Substituted Imidazoquinolines and Imidazonaphthyridines |
| 04/16/2009 | US20090099160 4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors |
| 04/16/2009 | US20090099156 Heterocyclic Compounds as Ccr2b antagonists |
| 04/16/2009 | US20090099152 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same |
| 04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 04/16/2009 | US20090099137 Anti-Inflammatory Compounds and Uses Thereof |
| 04/16/2009 | US20090099132 Proteasome inhibitors |
| 04/16/2009 | US20090099107 Methods and Compositions for Inhibition of Nuclear Factor kappaB |
| 04/16/2009 | US20090099106 Quinoline derivatives for modulating dna methylation |
| 04/16/2009 | US20090099103 Combinations of therapeutic agents for treating cancer |
| 04/16/2009 | US20090099102 Ginkgolides in the Treatment and Prevention of Ovarian Cancer |
| 04/16/2009 | US20090099100 Compositions and methods for treating amyloidosis |
| 04/16/2009 | US20090099094 Use of Somatostatin Agonists to Treat Medullary Thyroid Carcinoma |
| 04/16/2009 | US20090099092 Methods for stimulating fibroblast proliferation using substance p analogs |
| 04/16/2009 | US20090099090 Of given sequence; human leukocyte antigen; induce cytotoxic T cells; use of them as cancer vaccines, and methods for treatment and prevention of cancers based on them |
| 04/16/2009 | US20090099087 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 04/16/2009 | US20090099073 Albumin Fusion Proteins |
| 04/16/2009 | US20090099060 Modulation of line-1 reverse transcriptase |
| 04/16/2009 | US20090099037 Genomic Screen for Epigenetically Silenced Genes Associated With Cancer |
| 04/16/2009 | US20090098609 Il-2 fusion proteins with modulated selectivity |
| 04/16/2009 | US20090098569 Novel PGC-1 Isoforms and Uses Therefor |
| 04/16/2009 | US20090098544 Marker molecules associated with lung tumors |
| 04/16/2009 | US20090098210 antiproliferative agents, anticancer agents such as paclitaxel particles coated with albumin, and gemcitabine; pancreas cancer |
| 04/16/2009 | US20090098200 Compositions comprising lipophilic active compounds and method for their preparation |
| 04/16/2009 | US20090098197 Cancer vaccine comprising a cancer antigen based on the product of a tumor suppressor gene wt1 and a cationic liposome |
| 04/16/2009 | US20090098187 Composition And Its Use For The Manufacture Of A Medicament For Treating, Prophylactically Treating, Preventing Cancer And/Or Infections In The Urinary Tract |
| 04/16/2009 | US20090098138 Detection of proteins from circulating neoplastic cells |
| 04/16/2009 | US20090098137 Combinations of therapeutic agents for treating cancer |
| 04/16/2009 | US20090098135 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use |
| 04/16/2009 | US20090098133 3-Cyano-2-[3-(2-ethoxy-phenyl)-propanoylamino]-4,7-dihydro-5H-thieno[2,3-c]pyridine-6-carboxylic acid tert-butyl ester; cell-cycle specific inducers of apoptosis in cancer cells |
| 04/16/2009 | US20090098127 Agents Capable of Downregulating an MSF-A DEPENDENT HIF-1ALPHA and Use Thereof in Cancer Treatment |
| 04/16/2009 | US20090098125 PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 04/16/2009 | US20090098120 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098118 Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent |
| 04/16/2009 | US20090098117 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 04/16/2009 | US20090098116 Immunogenic compositions for induction of anti-tumor immunity |
| 04/16/2009 | US20090098112 Novel antibodies |
| 04/16/2009 | US20090098101 Compositions and methods for ribonuclease-based therapeutics |
| 04/16/2009 | US20090098100 Hormonally up-regulated, neu-tumor-associated kinase |
| 04/16/2009 | US20090098089 Reovirus for the treatment of neoplasia |
| 04/16/2009 | US20090098084 Parp inhibitor compounds, compositions and methods of use |
| 04/16/2009 | US20090098054 Methods and compositions relating to promoter regulation by muc1 and klf proteins |
| 04/16/2009 | US20090098046 Combination Cancer Therapy with Anti-PSMA Antibodies |
| 04/16/2009 | US20090098045 Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 04/16/2009 | CA2702366A1 Compositions affecting hyaluronic acid mediated activity |